Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice

Study Identifier
HUM 05-3
CT.gov Identifier
NCT01111240
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Psoriatic Arthritis (PsA)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Inclusion: * 18 years of age or older (younger patients may be enrolled at the discretion of physician) * Diagnosis of Psoriatic Arthritis (or any indication at the discretion of physician) and initiating adalimumab therapy * Signed/dated Informed Consent Exclusion: -None

    Protocol Summary

    This study is a documentation of effectiveness and safety of Humira in patients with psoriatic arthritis.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 35035
    Aachen, Germany, 52062
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 64288
    Aachen, Germany, 52062
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35509
    Ahlen, Germany, 59227
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 53118
    Ahrensburg, Germany, 22926
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35042
    Altenburg, Germany, 04600
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35045
    Altenholz, Germany, 24161
    Status
    Not applicable
    Showing {first} - {last} of {total} Results